LCNB Corp’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,218
Closed -$222K 167
2023
Q2
$222K Sell
3,218
-452
-12% -$32.2K 0.09% 169
2023
Q1
$273K Buy
3,670
+25
+0.7% +$2.1K 0.12% 152
2022
Q4
$340K Sell
3,645
-265
-7% -$25.6K 0.16% 131
2022
Q3
$373K Sell
3,910
-114
-3% -$11.3K 0.2% 117
2022
Q2
$373K Sell
4,024
-351
-8% -$34.3K 0.19% 121
2022
Q1
$443K Buy
4,375
+503
+13% +$52.8K 0.21% 111
2021
Q4
$399K Buy
3,872
+200
+5% +$18.5K 0.18% 119
2021
Q3
$312K Buy
3,672
+195
+6% +$16.3K 0.16% 125
2021
Q2
$290K Sell
3,477
-175
-5% -$14.3K 0.15% 129
2021
Q1
$275K Sell
3,652
-230
-6% -$16.8K 0.15% 131
2020
Q4
$265K Sell
3,882
-257
-6% -$16.7K 0.15% 130
2020
Q3
$242K Sell
4,139
-150
-3% -$9.33K 0.16% 123
2020
Q2
$279K Buy
4,289
+95
+2% +$5.98K 0.19% 112
2020
Q1
$249K Buy
4,194
+242
+6% +$16.2K 0.19% 109
2019
Q4
$293K Buy
3,952
+212
+6% +$14.9K 0.18% 117
2019
Q3
$236K Buy
+3,740
New +$222K 0.15% 132
2019
Q1
Sell
-6,011
Closed -$394K 135
2018
Q4
$394K Buy
6,011
+31
+0.5% +$2.31K 0.33% 81
2018
Q3
$471K Sell
5,980
-925
-13% -$66.1K 0.33% 84
2018
Q2
$444K Buy
+6,905
New +$455K 0.4% 66

Other funds holding CVS

LCNB Corp's CVS Position: Q3 2023 in Review

LCNB Corp sold out of CVS Health (CVS) in Q3 2023, closing a stake of 3,218 shares — an estimated $222K sold.

LCNB Corp first reported a position in CVS in Q2 2018 and held it in 19 quarters. The position peaked at $471K in Q3 2018. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • LCNB Corp reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • LCNB Corp sold 3,218 CVS Health shares in Q3 2023, an estimated $222K.
  • LCNB Corp first reported a position in CVS Health in Q2 2018 and held it in 19 quarters.
  • LCNB Corp's CVS Health position peaked at $471K in Q3 2018.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on LCNB Corp's 13F filing for Q3 2023, filed 13 Nov 2023.